02487.HK
Cutia Therapeutics
HKSE · Healthcare · Biotechnology · CN
HKD 1.20
−11.76%Leverage
- Debt / equity
- 0.39x
- Net debt / equity
- 0.17x
- Debt / assets
- 0.26x
- Debt / EBITDA
- -1.27x
- Net debt / EBITDA
- -0.56x
Liquidity & coverage
- Current ratio
- 3.85x
- Quick ratio
- 3.78x
- Cash ratio
- 2.94x
- Interest coverage
- -27.23x
- EBITDA / interest
- -24.30x
- Working capital
- HKD 711.3M
Cash & dividend
- FCF / debt
- -0.45x
- Cash flow / debt
- -0.44x
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jun 1, 2026